U.S. Markets close in 59 mins

5 Companies Hit 52-Week Highs

- By yifan900

According to GuruFocus list of 52-week highs , these Guru stocks have reached their 52-Week Highs.

CenterPoint Energy Inc. (CNP) reached the 52-week high of $29.38


CenterPoint Energy Inc. owns and operates a portfolio of energy-related businesses. The company primarily provides transmission and distribution services and has natural gas distribution systems in the U.S. CenterPoint Energy owns a portfolio of energy-related businesses. Its regulated electric utility provides transmission and distribution services to Houston and the surrounding area. The company has natural gas distribution systems in six states, including the cities of Houston and Minneapolis. CenterPoint owns approximately 54% of Enable Midstream Partners, a partnership consisting of natural gas processing and storage facilities and more than 21,000 miles of interstate, intrastate and gathering pipelines in the midcontinent region.

The price of CenterPoint Energy Inc. (CNP) shares have reached $29.38, which is 0.9% off the 52-week high of $29.63. CenterPoint Energy Inc. has a market cap of $14.73 billion; its shares were traded around $29.38 with a price-earnings ratio of 8.28 and price-sales ratio of 1.26. The trailing 12-month dividend yield of CenterPoint Energy Inc. stocks is 3.78%. The forward dividend yield of CenterPoint Energy Inc. stocks is 3.91%.

CenterPoint Energy Inc. recently reported net income available to common shareholders of $153 million, or 35 cents per diluted share, for the third quarter of 2018, compared with $169 million, or 39 cents per diluted share for the third quarter of 2017. Operating income for the third quarter of 2018 was $226 million, compared with $297 million in the third quarter of 2017.

Rogers Communications Inc. (RCI) reached the 52-week high of $54.58

Rogers Communications Inc. is the largest wireless carrier in Canada. The company provides cable network, Internet access, TV and phone services. Through its subsidiaries it owns the Sportsnet TV network. Rogers Communications is the largest wireless carrier in Canada, with close to 10 million subscribers, about 8 million of which are postpaid. It also owns an extensive cable network, passing 4 million homes in Ontario and the Atlantic region, and has 5 million total customer connections for Internet access, TV and phone services. Its media subsidiary owns the Toronto Blue Jays and Sportsnet TV network, which holds exclusive broadcasting rights to NHL and Blue Jays games.

The price of Rogers Communications Inc. shares has reached $54.58, which is 0.8% off the 52-week high of $55.02. Rogers Communications Inc. has a market cap of $28.07 billion; its shares were traded around $54.58 with a price-earnings ratio of 19.77 and price-sales ratio of 4.46. The trailing 12-month dividend yield of Rogers Communications Inc. stocks is 2.68%. The forward dividend yield of Rogers Communications Inc. stocks is 2.58%. Rogers Communications Inc. had an annual average earnings growth of 5.60% over the past 10 years.

Rogers Communications Inc. recently announced its unaudited financial and operating results for the third quarter ended Sept. 30, 2018. Highlights include:

-Total revenue growth of 3% and adjusted Ebitda growth of 8%.

-Service revenue growth of 5% and adjusted Ebitda growth of 8%.

-Cable revenue growth of 1% and adjusted Ebitda growth of 4%, margin expansion of 160 basis points.

-Continued strong Internet revenue growth of 8%.

-Internet net additions of 35,000, up 6,000.

-Increasing full-year 2018 guidance for adjusted Ebitda growth to 7-9% and for free cash flow growth to 5-7%.

Red Hat Inc. (RHT) reached the 52-week high of $176.06

Red Hat Inc. is a software company operating business across the world. It is primarily engaged in providing services to its version of the open-source Linux software operating systems, middleware, storage, virtualization and management tools. Red Hat provides services for its version of the open-source (free from licensing costs) Linux software operating systems, middleware, storage, virtualization and management tools. The company reports revenue through two categories: subscriptions and training, and services. The America contributed 60% of total revenue in fiscal 2015; Europe, the Middle East, and Africa contributed 25%; and Asia-Pacific contributed 15%.

The price of Red Hat Inc. shares has reached $176.06, which is 1.9% off the 52-week high of $179.49. Red Hat Inc. has a market cap of $31.12 billion; its shares were traded around $176.06 with a price-earnings ratio of 119.77 and price-sales ratio of 10.17. Red Hat Inc. had an annual average earnings growth of 15.60% over the past 10 years. GuruFocus rated Red Hat Inc. the business predictability rank of 4.5-star .

Red Hat Inc. recently announced financial results for the third quarter of fiscal year 2019 ended Nov. 30, 2018. Total revenue for the quarter was $847 million, up 13% year-over-year, or 15% measured in constant currency. GAAP operating income for the quarter was $109 million, down 8% year-over-year. GAAP net income for the quarter was $94 million, or 51 cents diluted earnings per share, compared with GAAP net income of $102 million, or 55 cents diluted earnings per share, in the year-ago quarter.

Regeneron Pharmaceuticals Inc. (REGN) reached the 52-week high of $408.63

Regeneron Pharmaceuticals Inc. is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron Pharmaceuticals discovers, develops and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.

The price of Regeneron Pharmaceuticals Inc. shares has reached $408.63, which is 1.9% off the 52-week high of $416.49. Regeneron Pharmaceuticals Inc. has a market cap of $44.23 billion; its shares were traded around $408.63 with a price-earnings ratio of 26.11 and price-sales ratio of 7.39. Regeneron Pharmaceuticals Inc. had an annual average earnings growth of 31.70% over the past five years.

Regeneron Pharmaceuticals Inc. recently announced financial results for the third quarter of 2018 and provided a business update. Net product sales were $1.025 billion in the third quarter of 2018, compared to $957 million in the third quarter of 2017. Total revenues, which include product revenues described above, increased by 11% to $1.663 billion in the third quarter of 2018, compared to $1.501 billion in the third quarter of 2017. GAAP net income was $595 million, or $5.50 per basic share and $5.17 per diluted share, in the third quarter of 2018, compared to GAAP net income of $388 million, or $3.64 per basic share and $3.32 per diluted share, in the third quarter of 2017.

Director Joseph L. Goldstein sold 1,791 shares of Regeneron Pharmaceuticals stock on Jan. 10, 2019, at the price of $410 per share. The price of the stock has decreased by 0.33% since.

Anthem Inc. (ANTX) reached the 52-week high of $56.86

Anthem Inc. is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and Specialty Business, Government Business and Other. With over 40 million medical members, Anthem is one of the largest managed-care organizations in the U.S. The firm provides health insurance services to its members through a plethora of products that encompass every major insurance market -- individual, group, and government-sponsored. The firm operates under the highly recognizable Blue Cross/Blue Shield brand in 14 states and has a large nationwide operation.

The price of Anthem Inc. shares has reached $56.86, which is -5.0% off the 52-week high of $54.01. Anthem Inc. has a market cap of $51.94 billion; its shares were traded around $56.86 with a price-earnings ratio of 14.89 and price-sales ratio of 0.74. The trailing 12-month dividend yield of Anthem Inc. stocks is 4.62%. The forward dividend yield of Anthem Inc. stocks is 4.62%. Anthem Inc. had an annual average earnings growth of 9.60% over the past 10 years. GuruFocus rated Anthem Inc. the business predictability rank of 4.5-star .

Anthem Inc. recently announced third quarter 2018 financial results. Highlights include:

-Third quarter net income was $960 million, growth of 29% over the prior year quarter. Adjusted net income of $3.81 per share grew by 44% year over year.

-Medical enrollment increased by 5,000 members sequentially, totaling approximately 39.5 million members as of Sept. 30, 2018.

-Benefit Expense Ratio was 84.8%, driven by solid medical cost performance.

-Full year 2018 GAAP net income is now expected to be greater than $14.46 per share. Full year 2018 adjusted net income is now expected to be greater than $15.60 per share.

Note: I do not own the stocks discussed.

This article first appeared on GuruFocus.